Evidence map›Paper›PMID 41792137›Full record

ArticleNature communications2026

AMR-GNN: a multi-representation graph neural network framework to enable genomic antimicrobial resistance prediction.

Hoai-An Nguyen, Anton Y Peleg, Jessica A Wisniewski, Xiaoyu Wang, Zhikang Wang, Luke V Blakeway, Gnei Z Badoordeen, Ravali Theegala, Nhu Quynh Doan, Matthew H Parker and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hoai-An NguyenDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0001-5345-2957
Anton Y PelegDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0002-2296-2126
Jessica A WisniewskiDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0002-9923-6579
Xiaoyu WangCentre to Impact AMR, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0003-4444-6197
Zhikang WangMonash Biomedicine Discovery Institute, Department of Biochemistry & Molecular Biology, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0001-9587-1965
Luke V BlakewayDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.
Gnei Z BadoordeenDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.
Ravali TheegalaDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.
Nhu Quynh DoanDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.
Matthew H ParkerDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia.ORCID http://orcid.org/0009-0007-2027-3195
Anna G GreenManning College of Information and Computer Sciences, University of Massachusetts, Amherst, MA, USA.ORCID http://orcid.org/0000-0001-7548-3682
Jiangning SongCentre to Impact AMR, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0001-8031-9086
David L DoweDepartment of Data Science & AI, Monash University, Melbourne, Australia.
Nenad MacesicDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia. nenad.macesic1@monash.edu.ORCID http://orcid.org/0000-0002-7905-628X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-genome sequencing (WGS) data are an invaluable resource for understanding antimicrobial resistance (AMR) mechanisms. However, WGS data are high-dimensional and the lack of standardized genomic representations is a key barrier to AMR phenotype prediction. To fully explore these high-resolution data, we propose AMR-GNN, a graph deep learning-based framework that integrates multiple genomic representations with graph neural networks (GNN) to enable AMR phenotype prediction from genomic sequence data. We test AMR-GNN with Pseudomonas aeruginosa, a clinically relevant Gram-negative bacterial pathogen known for its complex AMR mechanisms. We present AMR-GNN as a proof-of-concept framework designed to address several key problems in AMR phenotype prediction with data-driven machine learning (ML) approaches, including using multiple genomic representations to enhance performance, to mitigate the influence of clonal relationships and to identify informative biomarkers to provide explainability. Follow-up validation on the largest publicly available dataset spanning both Gram-negative and Gram-positive pathogens highlights AMR-GNN's broad applicability in detecting AMR in diverse and clinically relevant pathogen-drug combinations.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGenomicsGenome, BacterialGraph Neural NetworksHumansMachine LearningPhenotypePseudomonas aeruginosaWhole Genome SequencingAnti-Bacterial Agents

Identifiers

PMID41792137
PMCPMC13087051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.